- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 91,070 | 01.07.24 11:33:37 | +0,900 | +1,00% | 91,460 | 91,520 | 91,250 | 90,170 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 980,800 | 01.07.24 13:30:34 | +4,200 | +0,43% | 978,200 | 980,800 | 995,000 | 976,600 |
